http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2007004939-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
filingDate 2005-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d6019076822509e5667ca9850aa0ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c47117a26fb36d024128faed016183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed97d96d0a793216515b79caed2bf8d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df8f51eb69711363da6cfe89dbf41360
publicationDate 2007-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2007004939-A
titleOfInvention ALPHATIC AMINA POLYMER SALTS FOR TABLET FORMATION.
abstract The tablets, compositions and methods of the present invention comprising a carbonate salt of an aliphatic amine polymer and a monovalent anion s that can prevent or improve acidosis, in particular acidosis in patients with kidney disease. The tablets and compositions of the present invention maintain a disintegration time not exceeding 30 minutes at 37 degree C and a pH of at least 1 for a period of at least ten weeks at 60 degree C. In addition, the tablets are stable for long periods. of time without the need for special storage conditions.
priorityDate 2004-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523138

Total number of triples: 31.